Drugs / R-albuterol
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00320034 | Apr 2006 → Jun 2008 | asthma | Hamilton Health Sciences Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | R-albuterol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00320034 ↗ |
| Known as | levalbuterol | “R-albuterol ( levalbuterol) relieves the narrowing of the bronchial air passages in the lungs” NCT00320034 ↗ |